5GD-18025-57411
2 vaccinations
2 coded responses
26 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 287 / NC
- Registered
- 2022-12-09
- Relationship
- Child or adolescent in my care
- Guardian
- VT8-95062-32697
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-09
Registered in v-safe
-
2022-12-09
Dose 1 — Pfizer-BioNTechCo-administered: Flu:Hepatitis B:Hib:Rotavirus:Tetanus
- 2022-12-09
-
2022-12-10
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Site: Pain, Swelling/hardness · SleepinessUnder 3 check-in
-
2022-12-11
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
-
2022-12-12
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
- 2022-12-13
-
2022-12-14
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Constipation — Feeling: GoodFree text: ConstipationMedDRA releases: 2024-11 · check-in free text available
- 2022-12-15
- 2022-12-18
- 2022-12-23
- 2022-12-30
-
2023-01-06
Survey response — day 28, dose 1, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-06
Report sent to call center — day 28, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-09
Call successfulParticipant prefers to complete VAERS report online
- 2023-01-13
- 2023-01-20
-
2023-03-10
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2023-03-10
- 2023-03-10
- 2023-03-11
- 2023-03-12
- 2023-03-13
- 2023-03-14
- 2023-03-15
- 2023-03-16
- 2023-03-17
- 2023-03-24
- 2023-03-31
- 2023-04-07
- 2023-06-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-09 | Pfizer-BioNTech | Flu:Hepatitis B:Hib:Rotavirus:Tetanus |
| 2 | 2023-03-10 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-06 | Successful 2023-01-09 |
Participant prefers to complete VAERS report online |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Constipation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Constipation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release